Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil's Nicotrol is first nicotine patch switched by FDA; will be in stores by July 18.

This article was originally published in The Tan Sheet

Executive Summary

NICOTROL NICOTINE PATCH WILL BE ON SHELVES BY JULY 18, following July 3 approval from FDA for OTC marketing, McNeil Consumer announced. The transdermal patch will be available in a 15 mg strength to be used daily for six weeks. Nicotrol was unanimously recommended as safe and effective for over-the-counter use as a smoking cessation aid by FDA's Nonprescription Drugs Advisory Committee and members of the Drug Abuse Advisory Committee on April 19 ("The Tan Sheet" April 22, p. 1).
Advertisement

Related Content

OTC Nicotrol Tiered Dosing System Approved By FDA
OTC Nicotrol Tiered Dosing System Approved By FDA
OTC Nicotrol Tiered Dosing System Approved By FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS085567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel